Serb Pharmaceuticals
高管
查看带有其 13 名主要高管的组织结构图
Serb Pharmaceuticals 搜索最多的简介
- Vanessa Wolfeler, Chief Executive Officer
- Jeremie Urbain, Chairman of the Board
- Arthur Pignot, Chief Strategy Officer
高管在Serb Pharmaceuticals变化
- Vanessa Wolfeler已作为Chief Executive Officer加入公司 (新闻发布的2024六月1号).
创建提醒
跟踪 Serb Pharmaceuticals 的高管变动
药店
Serb Pharmaceuticals 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Serb Pharmaceuticals 的最新新闻稿
- SERB Pharmaceuticals expands leading emergency care portfolio with acquisition of Aurlumyn™ (iloprost IV) for severe frostbite - SERB Pharmaceuticals
- FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and priority review - SERB Pharmaceuticals
- SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million - SERB Pharmaceuticals
